Seeking Alpha

hautefearbrandnewgod

hautefearbrandnewgod
Send Message
View as an RSS Feed
View hautefearbrandnewgod's Comments BY TICKER:
Latest  |  Highest rated
  • OncoSec raises capital [View news story]
    i'm 100% sure that Pat is long.
    so am i.

    this is also music to my ears.
    Jun 5 05:34 PM | Likes Like |Link to Comment
  • OncoSec raises capital [View news story]
    A 5 year term for a warrant is standard. it does not mean that they think the PPS will be at .90 in 5 years LOL…
    Jun 5 05:32 PM | Likes Like |Link to Comment
  • OncoSec raises capital [View news story]
    yes kraus..that's the way of thinking about it for those without swiss cheese logic
    Jun 5 04:23 PM | Likes Like |Link to Comment
  • OncoSec Medical: Unique Electroporation Technology Delivering Cytokines To Target Cancer [View article]
    PVCT has a very sketchy management team imo. for years now they pumped PRs about FDA meetings and initiation of phase 3. nothing came of it.

    Then they switched to PRs about BTD designation application to pump another run to 6 dollars.

    How in Satan's name they intended to get a BTD designation when they've been unable to move forth even with a phase three is beyond me.

    Needless to say, FDA shut this notion down recently also, just like i said they would a few months ago.

    Now, if you look at the PRs, they're back to "we're intending to move forth with phase 3"…yawn

    they're like a broken record, playing to the tune of their dwindling PPS…

    20% drop just today…
    Jun 4 06:58 PM | Likes Like |Link to Comment
  • OncoSec Medical: Unique Electroporation Technology Delivering Cytokines To Target Cancer [View article]
    tom, my notions were not based on superstition, merely from the fact that for 4 years they've been unable to get a phase 3 trial. why?

    in absence of real explanations i revert to 1980 lol
    Jun 4 06:44 PM | Likes Like |Link to Comment
  • Acasti Pharma: An Undervalued Biotech With A Potential Best-In-Class Omega-3 Drug [View article]
    Insanely undervalued company.
    Jun 4 06:33 PM | Likes Like |Link to Comment
  • OncoSec Medical: Unique Electroporation Technology Delivering Cytokines To Target Cancer [View article]
    thanks Mack…i didn't wanna say i told em so but..err…you know
    May 28 11:11 AM | Likes Like |Link to Comment
  • Is OncoSec Medical Set To Trade Even Higher? [View article]
    lol...

    anyway, the annual ASCO meeting is a pretty important conference on oncology; i guess its fair to say that it's THE conference. companies submit abstracts and ASCO choses which ones are to present. the unique thing is that ASCO has a strict policy that companies can only submit new, previously unseen, top line data in their abstracts, and only those which are deemed impressive are chosen.
    ONCS submitted an abstract, which by itself means that we have positive new data to present (otherwise they would not have submitted it).
    The abstracts to be presented were made public on the ASCO website today.
    Looks like ONCS was chosen:

    From the website:

    • Systemic antitumor effect and clinical response in a phase 2 trial of intratumoral
    electroporation of plasmid interleukin-12 in patients with advanced melanoma. (Abstract
    9025^)
    Adil Daud
    Board 42"
    Apr 21 05:30 PM | Likes Like |Link to Comment
  • Is OncoSec Medical Set To Trade Even Higher? [View article]
    Al right, for those that were worried.

    "Spoke with Oncosec.
    There was nothing planned by the company at this time to offer those shares.It is more of a formality (as i said) to have for needed expenses and leverage...That's not to say they wont do a public offering with 25 million at 1.50$ or 2.00$.But more to have it on the books in case of emergency break here type of thing...Be on the look out for ASCO news..Would guess now that it's public it won't hurt to release it..."
    Apr 21 01:55 PM | Likes Like |Link to Comment
  • Is OncoSec Medical Set To Trade Even Higher? [View article]
    sweet new video http://bit.ly/1msgifI
    Apr 21 01:00 PM | Likes Like |Link to Comment
  • Is OncoSec Medical Set To Trade Even Higher? [View article]
    I'm not ruling that out hess; its the first of the options i listed...we'll see
    Apr 21 12:36 AM | Likes Like |Link to Comment
  • Is OncoSec Medical Set To Trade Even Higher? [View article]
    The S3 is just a shelf registration. Companies do one when the old one expires.
    Does not show intent to dilute; just a pre-emptive measure taken in times of expansion.,
    The S3 is NOT the filing of an offering.

    The shares registered could be used in various ways including but not limited to

    -share offerings in times of great runs (in case management expects substantial rallies in the near future)
    -as part of a private placement
    -as part of a business or partnership deal
    -etc

    bottomline is that we will only know the reason for these registered shares when the supplementary prospectus or further filing/ deal is finalized or posted…

    NO dilution will come from the S3 itself
    Apr 19 01:39 PM | 1 Like Like |Link to Comment
  • Is OncoSec Medical Set To Trade Even Higher? [View article]
    Awesome trading/investing bill, riding on house money is truly a great feeling!

    Not to bum you out dude, but i just wanna take issue with the term "pump and dump" in your post.
    You are right, there were some paid newsletter promos at the direction of Avtar Dhillon, at the inception of the company. However, this was hardly a pump and dump; rather, it was merely a way of introducing the new company to the public. Without investors/public interest a biotech will die before even starting their first phase. Trials need loads of money, and most start up biotechs secure funds through public offerings. Thus, without a "public" to provide demand and price appreciation, the offerings will be worthless and the company will perish soon after its born.
    So, think of Avtar's strategy as shrewd business; without this initial "word-spreading", ONCS might not be around, and the field would lose the benefits ONCS treatments are/will be providing. Since then, there have been no more paid promos for ONCS.
    So, were there paid promos in the beginning? Yes. Were these part of a scamming pump and dump scheme? Absolutely not. ONCS stellar track record since inception speaks for itself.
    Apr 4 04:42 PM | 5 Likes Like |Link to Comment
  • Marathon Patent Group's Wholly-Owned Subsidiary Signal IP, Inc. Files Patent Infringement Lawsuits Against American Honda Motor Corporation, KIA Motors America Corporation, Mazda Motor of America Corporation, and Mitsubishi Motors North America Corporation [View article]
    daym son mara be suin errbody yo spang and cox on fire dawg call da ambalamps
    Apr 2 09:17 PM | Likes Like |Link to Comment
  • Seeking Alpha And David Einhorn: The Real Story [View article]
    lol Paris,
    spoken like a true lawyer;
    ;)

    but you're not fooling anyone..
    Mar 25 02:38 PM | Likes Like |Link to Comment
COMMENTS STATS
225 Comments
279 Likes